MORPHOLINE DERIVATIVES

Details for Australian Patent Application No. 2003269923 (hide)

Owner ELI LILLY AND COMPANY

Inventors HAUGHTON, Helen, Louise; RUDYK, Helene, Catherine, Eugenie; WALTER, Magnus, Wilhelm; CLARK, Barry, Peter; GALLAGHER, Peter, Thaddeus

Pub. Number AU-A-2003269923

PCT Number PCT/US03/23269

PCT Pub. Number WO2004/017977

Priority 0219690.5 23.08.02 GB; 60/415,328 01.10.02 US

Filing date 18 August 2003

Wipo publication date 11 March 2004

International Classifications

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

A61P 025/00 Drugs for disorders of the nervous system

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 0219690.5 23.08.02 GB; 60/415,328 01.10.02 US

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2003269923

23 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003269924-Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

2003269922-NUCLEIC ACID-ASSOCIATED PROTEINS